🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase II multicenter, Canadian only study - open to 25 subjects. Study open...
Status
Unknown
Location
Hospital Maissoneuve
Start Date
2016-03
Trial ID
NCT02519816
The primary purpose of this Phase 1 study is to evaluate the safety, tolera...
Status
Terminated
Location
University of California, San Francisco
Start Date
2015-08-27
Trial ID
NCT02428309
Treatments Being Tested
The investigational product, named Ovasave (Ova-Treg), is a cell-based ther...
Status
Terminated
Location
Medical University Innsbruck
Start Date
2014-12
Trial ID
NCT02327221
The purpose of this study is to evaluate the safety and tolerability of QEL...
Status
Active Not Recruiting
Location
H. Saint Luc
Start Date
2022-01-21
Trial ID
NCT05234190
Treatments Being Tested
This study is a randomized, placebo-controlled, phase 2a trial to study the...
Status
Active Not Recruiting
Location
Massachusetts General Hospital Neurological Clinical Research Institute
Start Date
2019-08-07
Trial ID
NCT04055623
This clinical trial will explore the safety and effect of autologous ex viv...
Status
Completed
Location
Rady Children's Hospital
Start Date
2016-02
Trial ID
NCT02691247
Treatments Being Tested
RATIONALE: Combinations of biological substances in denileukin diftitox may...
Status
Completed
Location
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Start Date
2005-09
Trial ID
NCT00128622
20 patients with invasive castration resistant prostate cancer and radiolog...
Status
Completed
Location
Haukeland University Hospital Research Department
Start Date
2015-05
Trial ID
NCT02423928
Treatments Being Tested
This phase I/II trials evaluates the feasibility, safety and efficacy of an...
Status
Completed
Location
University Children's Hospital
Start Date
2018-02-07
Trial ID
NCT03879512
Treatments Being Tested
This randomized phase II trial is studying how well giving vaccine therapy ...
Status
Terminated
Location
National Cancer Institute Surgery Branch
Start Date
2005-11
Trial ID
NCT00303836